|
|
Article: LAM Pharmaceuticals' Medical Team to Facilitate Product Training of Chinese Medical Professionals.
- Article from:
- PR Newswire
- Article date:
- May 4, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LAM Pharmaceutical, Corp. (OTC Bulletin Board: LAMP; Frankfurt: LAM; Berlin: LAM), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that the medical team that led the U.S. human study of the LAM IPM Wound Gel is committed to supporting the Company's market entry into China. Welcomed and endorsed by LAM's China distribution partner, the team will work with Sinopharm to ensure Chinese medical professionals, starting with major hospitals in Beijing, Shanghai and Guangzhou, receive proper training regarding the IPM Wound Gel.
Joseph Slechta, President and Chief ...